Recurrent Pregnancy Loss: A Bibliometric Review
,
Abstract
Background: The research combined different bibliometric techniques to analyze systematically recurrent pregnancy loss (RPL) documents from 1970 to 2023.
Methods: Overall, 1287 documents from the Web of Science database associated with recurrent pregnancy loss between 1970 and 2023 were identified for more than 300 journals. The data were analyzed with VOSviewer software.
Results: The trend of paying attention to the topic of RPL can be divided into three periods. The number of publications on RPL increased significantly after 2010. Most of the papers were published in Obstetrics and Gynecology and Reproductive Biology areas. Utilizing co-occurrence and co-citation analysis, our study found that the most influential documents mapped the knowledge structure, and projected future research directions. The co-occurrence analysis showed five clusters even though the co-citation analysis designates four.
Conclusion: RPL has increased in recent years exponentially and some areas were explained carefully, therefore these results could be used as a research agenda for the future direction by a range of interested beneficiaries.
1. Iews M, Tan J, Taskin O, et al. (2018). Does preimplantation genetic diagnosis improve reproductive outcome in couples with recurrent pregnancy loss owing to structural chromosomal rearrangement? A systematic review. Reprod Biomed Online,36(6):677–85.
2. Dimitriadis E, Menkhorst E, Saito S, et al (2020). Recurrent pregnancy loss. Nat Rev Dis Primers, 6(1):98.
3. Yu WL, Bao SH (2022). Association of male factors with recurrent pregnancy loss. J Reprod Immunol,154: 103758.
4. Dasari P, Suganya G (2022). Outcome of Index Pregnancy in Women with Recurrent Pregnancy Loss (RPL). J Obstet Gynaecol India, 72(Suppl 1):152-158.
5. Giancotti A, La Torre R, Spagnuolo A, et al. (2012). Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. J Matern Fetal Neonatal Med, 25(7):1191–4.
6. Donckers J, Scholten RR, Oyen WJG, et al (2012). Unexplained first trimester recurrent pregnancy loss and low venous reserves. Hum Reprod, 27(9):2613–8.
7. Chen R, Wei Y, Xu X, et al. (2022). A bibliometric analysis of chronic subdural hematoma since the twenty-first century. Eur J Med Res, 27(1):309.
8. Tantengco OAG, De Jesus FCC, Gampoy EFS, et al (2021). Molar pregnancy in the last 50 years: A bibliometric analysis of global research output. Placenta,112:54–61.
9. Akbari R, Hantoushzadeh S, Panahi Z, et al (2023). A bibliometric review of 35 years of studies about preeclampsia. Front Physiol, 14:1110399.
10. Kazemi Aski S, Akbari R, Hantoushzadeh S, et al (2020). A bibliometric analysis of Intrauterine Growth Restriction research. Placenta, 95:106–20.
11. Small H (1973). Co-citation in the scientific literature: A new measure of the relationship between two documents. J Am Soc Inf Sci, 24:265–9.
12. Noyons ECM, Moed HF, Luwel M (1999). Combining Mapping and Citation Analysis for Evaluative Bibliometric Purposes : A Bibliometric Study. J Am Soc Inf Sci, 50(2):115–31.
13. Ruggeri G, Orsi L, Corsi S (2019). A bibliometric analysis of the scientific literature on Fairtrade labelling. Int J Consum Stud, 43(2):134–52.
14. Cobo MJ, López-Herrera AG, Herrera-Viedma E, et al (2011). An approach for detecting, quantifying, and visualizing the evolution of a research field: A practical application to the Fuzzy Sets Theory field. Journal of Informetrics,, 5(1):146–66.
15. Fu Z, Lv J, Gao X, et al (2023). Research trends and hotspots evolution of cardiac amyloidosis: a bibliometric analysis from 2000 to 2022. Eur J Med Res, 28(1):89.
16. Van Eck NJ, Waltman L (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 84(2):523–38.
17. Practice Committee of the American Society for Reproductive-Medicine (2012). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril, 98(5):1103–11.
18. Kutteh WH (1996). Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol,174(5):1584–9.
19. Atik RB, Christiansen OB, Elson J, et al (2018). ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open, 2018(2):hoy004.
20. Med ASR (2013). Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril, 99(1):63.
21. Harger JH, Archer DF, Marchese SG, et al (1983). Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol, 62(5):574–81.
22. Med ASR (2008). Definitions of infertility and recurrent pregnancy loss. Fertil Steril, 90(5 Suppl):S60.
23. Med ASR (2020). Definitions of infertility and recurrent pregnancy loss: A committee opinion. Fertil Steril, 113(3):533–5.
24. Scott JR, Branch DW, Kochenour NK, et al (1988). Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and rh immunization. Am J Obstet Gynecol, 159(5):1055–6.
25. Brenner B, Hoffman R, Carp H, et al (2005). Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost, 3(2):227–9.
26. Kutteh WH, Park VM, Deitcher SR (1999). Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril, 71(6):1048–53.
27. Kutteh WH, Yetman DL, Carr AC, et al (1999). Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril, 71(5):843–8.
28. Yetman DL, Kutteh WH (1996). Antiphospholipid antibody panels and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril, 66(4):540–6.
29. Brenner B, Hoffman R, Blumenfeld Z, et al (2000). Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost, 83(5):693–7.
30. Kwak-Kim JYH, Chung-Bang HS, Ng SC, et al (2003). Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod, 18(4):767–73.
31. Salker M, Teklenburg G, Molokhia M, et al (2010). Natural Selection of Human Embryos: Impaired Decidualization of Endometrium Disables Embryo-Maternal Interactions and Causes Recurrent Pregnancy Loss. PLoS One, 5(4): e10287.
32. Carrell DT, Liu L, Peterson CM, et al (2003). Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl, 49(1):49–55.
33. Laskin CA, Spitzer KA, Clark CA, et al (2009). Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial. J Rheumatol, 36(2):279–87.
34. Trujillo CM, Long TM (2018). Document co-citation analysis to enhance transdisciplinary research. Sci Adv, 4(1): e1701130.
35. Rai R, Regan L (2006). Recurrent miscarriage. Lancet, 368(9535):601–11.
36. Jaslow CR, Carney JL, Kutteh WH (2010). Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril,93(4):1234–43.
37. Christiansen OB, Steffensen R, Nielsen HS, et al (2008). Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol Obstet Invest, 66(4):257–67.
38. Jauniaux E, Farquharson RG, Christiansen OB, et al (2006). O behalf of ESIG for EP. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod, 21(9):2216–22.
39. Kolte AM, Bernardi LA, Christiansen OB, et al (2015). Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod, 30(3):495–8.
40. Larsen EC, Christiansen OB, Kolte AM, et al(2013). New insights into mechanisms behind miscarriage. BMC Med,11:154.
41. Li TC, Makris M, Tomsu M, et al (2002). Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update, 8(5):463–81.
42. Brigham SA, Conlon C, Farquharson RG (1999). A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod, 14(11):2868–71.
43. Nybo Andersen AM, Wohlfahrt J, Christens P, et al (2000). Maternal age and fetal loss: population based register linkage study. BMJ, 320(7251):1708–12.
44. Clifford K, Rai R, Regan L (1997). Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod, 12(2):387–9.
45. Stephenson M, Kutteh W (2007). Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol, 50(1):132–45.
46. Stray-Pedersen B, Stray-Pedersen S (1984). Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol, 148(2):140–6.
47. Christiansen OB, Nybo Andersen A-M, Bosch E, et al (2005). Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril, 83(4):821–39.
48. Clifford K, Rai R, Watson H, Regan L (1994). An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod, 9(7):1328–32.
49. Kovalevsky G, Gracia CR, Berlin JA, et al (2004). Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss - A meta-analysis. Arch Intern Med,164:558–63.
50. Coulam CB, Jeyendran RS, Fishel LA, Roussev R (2006). Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol, 55(5):360–8.
51. Goodman CS, Coulam CB, Jeyendran RS, et al (2006). Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol, 56(4):230–6.
52. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10(1):111–3.
53. Preston FE, Rosendaal FR, Walker ID, et al (1996). Increased fetal loss in women with heritable thrombophilia. Lancet, 348(9032):913–6.
54. Rey E, Kahn SR, David M, Shrier I (2003). Thrombophilic disorders and fetal loss: a meta-analysis. Lancet, 361(9361):901–8.
55. Robertson L, Wu O, Langhorne P, et al (2006). Thrombophilia in pregnancy: a systematic review. Br J Haematol, 132(2):171–96.
56. Sugiura-Ogasawara M, Ozaki Y, Katano K, et al (2012). Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod, 27(8):2297–303.
57. Kaandorp SP, Goddijn M, van der Post JAM, et al (2010). Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med, 362(17):1586–96.
58. Miyakis S, Lockshin MD, Atsumi T, et al (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost, 4(2):295–306.
59. Branch DW, Gibson M, Silver RM (2010). Clinical practice. Recurrent miscarriage. N Engl J Med, 363(18):1740–7.
60. Glänzel W, Schubert A (2005). Analysing Scientific Networks Through Co-Authorship BT - Handbook of Quantitative Science and Technology Research: The Use of Publication and Patent Statistics in Studies of S&T Systems. In: Moed HF, Glänzel W, Schmoch U, editors. Dordrecht: Springer Netherlands; 257–76.
61. Shapira E, Ratzon R, Shoham-Vardi I, et al (2012). Primary vs. secondary recurrent pregnancy loss - epidemiological characteristics, etiology, and next pregnancy outcome. J Perinat Med, 40(4):389–96.
62. Musters AM, Taminiau-Bloem EF, van den Boogaard E, et al (2011). Supportive care for women with unexplained recurrent miscarriage: patients’ perspectives. Hum Reprod, 26(4):873–7.
2. Dimitriadis E, Menkhorst E, Saito S, et al (2020). Recurrent pregnancy loss. Nat Rev Dis Primers, 6(1):98.
3. Yu WL, Bao SH (2022). Association of male factors with recurrent pregnancy loss. J Reprod Immunol,154: 103758.
4. Dasari P, Suganya G (2022). Outcome of Index Pregnancy in Women with Recurrent Pregnancy Loss (RPL). J Obstet Gynaecol India, 72(Suppl 1):152-158.
5. Giancotti A, La Torre R, Spagnuolo A, et al. (2012). Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss. J Matern Fetal Neonatal Med, 25(7):1191–4.
6. Donckers J, Scholten RR, Oyen WJG, et al (2012). Unexplained first trimester recurrent pregnancy loss and low venous reserves. Hum Reprod, 27(9):2613–8.
7. Chen R, Wei Y, Xu X, et al. (2022). A bibliometric analysis of chronic subdural hematoma since the twenty-first century. Eur J Med Res, 27(1):309.
8. Tantengco OAG, De Jesus FCC, Gampoy EFS, et al (2021). Molar pregnancy in the last 50 years: A bibliometric analysis of global research output. Placenta,112:54–61.
9. Akbari R, Hantoushzadeh S, Panahi Z, et al (2023). A bibliometric review of 35 years of studies about preeclampsia. Front Physiol, 14:1110399.
10. Kazemi Aski S, Akbari R, Hantoushzadeh S, et al (2020). A bibliometric analysis of Intrauterine Growth Restriction research. Placenta, 95:106–20.
11. Small H (1973). Co-citation in the scientific literature: A new measure of the relationship between two documents. J Am Soc Inf Sci, 24:265–9.
12. Noyons ECM, Moed HF, Luwel M (1999). Combining Mapping and Citation Analysis for Evaluative Bibliometric Purposes : A Bibliometric Study. J Am Soc Inf Sci, 50(2):115–31.
13. Ruggeri G, Orsi L, Corsi S (2019). A bibliometric analysis of the scientific literature on Fairtrade labelling. Int J Consum Stud, 43(2):134–52.
14. Cobo MJ, López-Herrera AG, Herrera-Viedma E, et al (2011). An approach for detecting, quantifying, and visualizing the evolution of a research field: A practical application to the Fuzzy Sets Theory field. Journal of Informetrics,, 5(1):146–66.
15. Fu Z, Lv J, Gao X, et al (2023). Research trends and hotspots evolution of cardiac amyloidosis: a bibliometric analysis from 2000 to 2022. Eur J Med Res, 28(1):89.
16. Van Eck NJ, Waltman L (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 84(2):523–38.
17. Practice Committee of the American Society for Reproductive-Medicine (2012). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril, 98(5):1103–11.
18. Kutteh WH (1996). Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol,174(5):1584–9.
19. Atik RB, Christiansen OB, Elson J, et al (2018). ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open, 2018(2):hoy004.
20. Med ASR (2013). Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril, 99(1):63.
21. Harger JH, Archer DF, Marchese SG, et al (1983). Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol, 62(5):574–81.
22. Med ASR (2008). Definitions of infertility and recurrent pregnancy loss. Fertil Steril, 90(5 Suppl):S60.
23. Med ASR (2020). Definitions of infertility and recurrent pregnancy loss: A committee opinion. Fertil Steril, 113(3):533–5.
24. Scott JR, Branch DW, Kochenour NK, et al (1988). Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and rh immunization. Am J Obstet Gynecol, 159(5):1055–6.
25. Brenner B, Hoffman R, Carp H, et al (2005). Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost, 3(2):227–9.
26. Kutteh WH, Park VM, Deitcher SR (1999). Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril, 71(6):1048–53.
27. Kutteh WH, Yetman DL, Carr AC, et al (1999). Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril, 71(5):843–8.
28. Yetman DL, Kutteh WH (1996). Antiphospholipid antibody panels and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril, 66(4):540–6.
29. Brenner B, Hoffman R, Blumenfeld Z, et al (2000). Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost, 83(5):693–7.
30. Kwak-Kim JYH, Chung-Bang HS, Ng SC, et al (2003). Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod, 18(4):767–73.
31. Salker M, Teklenburg G, Molokhia M, et al (2010). Natural Selection of Human Embryos: Impaired Decidualization of Endometrium Disables Embryo-Maternal Interactions and Causes Recurrent Pregnancy Loss. PLoS One, 5(4): e10287.
32. Carrell DT, Liu L, Peterson CM, et al (2003). Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl, 49(1):49–55.
33. Laskin CA, Spitzer KA, Clark CA, et al (2009). Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial. J Rheumatol, 36(2):279–87.
34. Trujillo CM, Long TM (2018). Document co-citation analysis to enhance transdisciplinary research. Sci Adv, 4(1): e1701130.
35. Rai R, Regan L (2006). Recurrent miscarriage. Lancet, 368(9535):601–11.
36. Jaslow CR, Carney JL, Kutteh WH (2010). Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril,93(4):1234–43.
37. Christiansen OB, Steffensen R, Nielsen HS, et al (2008). Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol Obstet Invest, 66(4):257–67.
38. Jauniaux E, Farquharson RG, Christiansen OB, et al (2006). O behalf of ESIG for EP. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod, 21(9):2216–22.
39. Kolte AM, Bernardi LA, Christiansen OB, et al (2015). Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod, 30(3):495–8.
40. Larsen EC, Christiansen OB, Kolte AM, et al(2013). New insights into mechanisms behind miscarriage. BMC Med,11:154.
41. Li TC, Makris M, Tomsu M, et al (2002). Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update, 8(5):463–81.
42. Brigham SA, Conlon C, Farquharson RG (1999). A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod, 14(11):2868–71.
43. Nybo Andersen AM, Wohlfahrt J, Christens P, et al (2000). Maternal age and fetal loss: population based register linkage study. BMJ, 320(7251):1708–12.
44. Clifford K, Rai R, Regan L (1997). Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod, 12(2):387–9.
45. Stephenson M, Kutteh W (2007). Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol, 50(1):132–45.
46. Stray-Pedersen B, Stray-Pedersen S (1984). Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol, 148(2):140–6.
47. Christiansen OB, Nybo Andersen A-M, Bosch E, et al (2005). Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril, 83(4):821–39.
48. Clifford K, Rai R, Watson H, Regan L (1994). An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod, 9(7):1328–32.
49. Kovalevsky G, Gracia CR, Berlin JA, et al (2004). Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss - A meta-analysis. Arch Intern Med,164:558–63.
50. Coulam CB, Jeyendran RS, Fishel LA, Roussev R (2006). Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol, 55(5):360–8.
51. Goodman CS, Coulam CB, Jeyendran RS, et al (2006). Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol, 56(4):230–6.
52. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10(1):111–3.
53. Preston FE, Rosendaal FR, Walker ID, et al (1996). Increased fetal loss in women with heritable thrombophilia. Lancet, 348(9032):913–6.
54. Rey E, Kahn SR, David M, Shrier I (2003). Thrombophilic disorders and fetal loss: a meta-analysis. Lancet, 361(9361):901–8.
55. Robertson L, Wu O, Langhorne P, et al (2006). Thrombophilia in pregnancy: a systematic review. Br J Haematol, 132(2):171–96.
56. Sugiura-Ogasawara M, Ozaki Y, Katano K, et al (2012). Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod, 27(8):2297–303.
57. Kaandorp SP, Goddijn M, van der Post JAM, et al (2010). Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med, 362(17):1586–96.
58. Miyakis S, Lockshin MD, Atsumi T, et al (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost, 4(2):295–306.
59. Branch DW, Gibson M, Silver RM (2010). Clinical practice. Recurrent miscarriage. N Engl J Med, 363(18):1740–7.
60. Glänzel W, Schubert A (2005). Analysing Scientific Networks Through Co-Authorship BT - Handbook of Quantitative Science and Technology Research: The Use of Publication and Patent Statistics in Studies of S&T Systems. In: Moed HF, Glänzel W, Schmoch U, editors. Dordrecht: Springer Netherlands; 257–76.
61. Shapira E, Ratzon R, Shoham-Vardi I, et al (2012). Primary vs. secondary recurrent pregnancy loss - epidemiological characteristics, etiology, and next pregnancy outcome. J Perinat Med, 40(4):389–96.
62. Musters AM, Taminiau-Bloem EF, van den Boogaard E, et al (2011). Supportive care for women with unexplained recurrent miscarriage: patients’ perspectives. Hum Reprod, 26(4):873–7.
| Files | ||
| Issue | Vol 53 No 7 (2024) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v53i7.16057 | |
| Keywords | ||
| Recurrent pregnancy loss Bibliometric Co-occurrence Co-citation Web of science database | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Panahi Z, Akbari R, Ghaemi M. Recurrent Pregnancy Loss: A Bibliometric Review. Iran J Public Health. 2024;53(7):1629-1639.
